ClinicalTrials.Veeva

Menu

Epidemiology of Sepsis in Turkish ICUs.

N

Nur Baykara

Status

Completed

Conditions

Severe Sepsis
Septic Shock
Sepsis

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT03249246
TurkishICS

Details and patient eligibility

About

The prevalence and mortality of sepsis in Turkey is not know at large. Turkish Society of Intensive Care Medicine, Sepsis Study Group conducted a multi-centre,point prevalence survey to determine the prevalence, causative micro-organisms and outcome of sepsis in Turkish ICUs.

Enrollment

1,499 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:All patients present on or admitted to participating ICU on study day.

Exclusion Criteria:

  • Age<18 years
  • Patients who underwent cardiovascular surgery.

Trial design

1,499 participants in 4 patient groups

Infection only
Description:
The patients have only infection
Treatment:
Other: No intervention
Infection + SIRS
Description:
Patients have infection plus systemic inflammatory response syndrome (SIRS)
Treatment:
Other: No intervention
Severe sepsis
Description:
Septic patients with newly developed organ dysfunctions
Treatment:
Other: No intervention
Septic shock
Description:
Sepsis plus sepsis related hypotension
Treatment:
Other: No intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems